Anadis Ltd’s clinical trial against mucositis approved in Israel Anadis Ltd mildronate-meldonium.com/mildronate-faq.html ., an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and additional proteins is normally announcing the clinical protocol for its Cancer-related Mucositis System was cleared by the Tel Aviv Souraski Medical Center’s Institutional Review Plank and by the Israeli Ministry of Wellness . This permits the initiation of the scientific trial addressing this significant target at the medical center within per month. Related StoriesStudy shows rare HER2 missense mutations do not spread breasts cancer on their ownMD Anderson study reveals why chemotherapy medicines not effective for many pancreatic cancers patientsSausages With Antioxidants From Berries To Prevent CancerMucositis is a substantial side effect in cancer therapy .